Titelia

Holdings of 5AM Venture Management, LLC

17 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 86.1 % of the equity sleeve

Sector breakdown

  • Unattributed 100.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 99.2 %
  • GB 0.8 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1US16320.9M $99.22 %
2GB12.5M $0.78 %

Positions

RankCompanySharesValueWeight
1Erasca Inc 3,485,97156.4M $
2Entrada Therapeutics Inc 4,056,37951.2M $
3Tyra Biosciences Inc 1,029,29839.4M $
4CAMP4 THERAPEUTICS CORP 5,869,09125.9M $
5CENTESSA PHARMACEUTICALS PLC 580,94523.1M $
6MapLight Therapeutics Inc 950,01119.3M $
7Tectonic Therapeutic Inc 606,66018.8M $
8Celldex Therapeutics Inc 497,27015.8M $
9Artiva Biotherapeutics Inc 2,353,30415.2M $
10EyePoint Inc 1,050,00013.5M $
11Surrozen Inc 387,50011.3M $
12Zentalis Pharmaceuticals Inc 3,947,9139.2M $
13Protara Therapeutics Inc 1,369,7827.1M $
14ALX Oncology Holdings Inc 3,057,3256.1M $
15SKYE BIOSCIENCE INC 9,681,7636M $
16RALLYBIO CORP 291,7882.6M $
17Silence Therapeutics PLC 476,2002.5M $